Procter & Gamble Company (The) $PG Shares Sold by Mesirow Financial Investment Management Inc.

Mesirow Financial Investment Management Inc. lowered its holdings in shares of Procter & Gamble Company (The) (NYSE:PG) by 5.5% during the 3rd quarter, Holdings Channel reports. The fund owned 61,763 shares of the company’s stock after selling 3,581 shares during the period. Mesirow Financial Investment Management Inc.’s holdings in Procter & Gamble were worth $9,490,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently modified their holdings of PG. Halbert Hargrove Global Advisors LLC bought a new position in shares of Procter & Gamble in the third quarter valued at approximately $25,000. Corundum Trust Company INC acquired a new position in shares of Procter & Gamble during the 3rd quarter valued at $32,000. Marquette Asset Management LLC acquired a new stake in shares of Procter & Gamble in the third quarter valued at $37,000. Redmont Wealth Advisors LLC acquired a new stake in shares of Procter & Gamble in the third quarter valued at $40,000. Finally, Manning & Napier Advisors LLC bought a new position in Procter & Gamble during the third quarter valued at about $44,000. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Trading Down 1.1%

Procter & Gamble stock opened at $163.45 on Thursday. Procter & Gamble Company has a 12 month low of $137.62 and a 12 month high of $179.99. The company has a quick ratio of 0.51, a current ratio of 0.72 and a debt-to-equity ratio of 0.49. The business has a 50 day moving average price of $150.14 and a two-hundred day moving average price of $150.94. The stock has a market cap of $379.85 billion, a price-to-earnings ratio of 24.21, a price-to-earnings-growth ratio of 5.52 and a beta of 0.38.

Procter & Gamble (NYSE:PG) last posted its earnings results on Thursday, January 22nd. The company reported $1.88 earnings per share for the quarter, topping the consensus estimate of $1.86 by $0.02. The business had revenue of $22.21 billion for the quarter, compared to analyst estimates of $22.36 billion. Procter & Gamble had a net margin of 19.30% and a return on equity of 32.21%. The firm’s quarterly revenue was up 1.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.88 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities analysts forecast that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, February 17th. Stockholders of record on Friday, January 23rd were given a dividend of $1.0568 per share. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date of this dividend was Friday, January 23rd. Procter & Gamble’s dividend payout ratio (DPR) is currently 62.67%.

Key Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: New product launches and sustainability push (Tide evo concentrated, waterless detergent tile; Head & Shoulders BARE scalp serum) support premiumization, ESG positioning and potentially higher margins — a structural driver of investor enthusiasm. P&G Sustainability Push And New Formats Underpin Valuation Case
• Positive Sentiment: Recent results: P&G topped fiscal Q2 EPS estimates and reiterated FY‑26 guidance (6.83–7.09 EPS), which has prompted analyst upgrades and helped fuel a short‑term rally. Assessing Procter & Gamble (PG) Valuation After Earnings Beat And Tide Evo Launch
• Positive Sentiment: Portfolio rationalization efforts aim to streamline SKUs and focus investment on higher‑growth categories — a strategic move that can boost agility and margin expansion over time. Is Portfolio Rationalization the Key to Procter & Gamble’s Agility?
• Neutral Sentiment: Analyst and peer comparisons are mixed: some firms raise targets and reaffirm buys while others remain neutral, reflecting differing views on growth vs valuation. MarketBeat coverage and analyst notes
• Neutral Sentiment: Market action: P&G has been a visible driver in futures/market moves at times, but that can amplify intraday swings unrelated to fundamentals. Procter & Gamble Leads the Way In S&P 500 Futures Trends
• Negative Sentiment: Insider selling disclosed: Director/executive sell of ~1,809 shares (~$288k) was filed — a small but visible signal that can add to intraday selling pressure. Procter & Gamble Insider Sells $288,463.14 in Stock
• Negative Sentiment: Valuation and relative underperformance: P&G has lagged the staples group over the last year and some analysts warn of limited near‑term upside versus peers, which can prompt profit‑taking after the recent 30‑day strength. How Is Procter & Gamble’s Stock Performance Compared to Other Consumer Staples Stocks?
• Negative Sentiment: Analyst caution piece highlights one reason to stay skeptical (valuation/competition), reinforcing mixed sentiment that can weigh on the name intraday. 2 Reasons to Like PG and 1 to Stay Skeptical

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the stock. Wells Fargo & Company restated an “overweight” rating and issued a $177.00 price target on shares of Procter & Gamble in a research report on Tuesday, February 17th. TD Cowen lowered Procter & Gamble from a “buy” rating to a “hold” rating and boosted their target price for the stock from $150.00 to $156.00 in a research report on Tuesday, January 27th. Barclays set a $155.00 price target on Procter & Gamble in a research report on Friday, January 16th. Dbs Bank raised shares of Procter & Gamble from a “hold” rating to a “buy” rating in a research note on Friday, January 23rd. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on shares of Procter & Gamble from $176.00 to $171.00 and set a “buy” rating for the company in a report on Monday, December 8th. Fourteen research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat, Procter & Gamble has an average rating of “Moderate Buy” and an average price target of $168.33.

Insider Buying and Selling at Procter & Gamble

In related news, insider Susan Street Whaley sold 1,809 shares of the stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $159.46, for a total transaction of $288,463.14. Following the completion of the sale, the insider directly owned 30,215 shares of the company’s stock, valued at approximately $4,818,083.90. This represents a 5.65% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Chairman Jon R. Moeller sold 162,232 shares of the company’s stock in a transaction that occurred on Thursday, February 12th. The shares were sold at an average price of $162.45, for a total transaction of $26,354,588.40. Following the completion of the transaction, the chairman owned 319,385 shares of the company’s stock, valued at $51,884,093.25. This trade represents a 33.68% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 343,069 shares of company stock worth $54,545,448 in the last three months. 0.20% of the stock is owned by insiders.

Procter & Gamble Company Profile

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.